The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Mineral Metabolism

Background:

• Arterial calcification is highly prevalent in end-stage renal disease (ESRD), exceeding risks from common factors like aging and diabetes.
• Vascular and valvular calcifications in chronic kidney disease (CKD) predict cardiovascular events and mortality.
• ESRD-specific factors like phosphate retention, excess calcium, and dialysis duration exacerbate vascular calcification.

Purpose of the Study:

• To explore the multifactorial nature of vascular calcification in ESRD.
• To identify strategies for reversing or preventing arterial calcification in CKD patients.
• To highlight the importance of balancing vascular health with bone integrity during treatment.

Main Methods:

• Review of existing literature on cardiovascular risk factors and calcification in ESRD.
• Analysis of ESRD-specific contributors to vascular calcification.
• Evaluation of therapeutic strategies targeting inflammation, mineral balance, and bone turnover.

Main Results:

• ESRD-related risks (phosphate, calcium, dialysis) significantly contribute to vascular calcification alongside traditional factors.
• Strategies include minimizing inflammation, correcting bone turnover abnormalities, and restoring anticalcification factors (e.g., Vitamin D, K).
• The efficacy of bone antiresorption therapies and the potential of sodium thiosulfate require further investigation.

Conclusions:

• Addressing the "calcium paradox" and reducing procalcific factors are crucial for managing vascular calcification in ESRD.
• Therapeutic interventions must consider potential impacts on bone health.
• Integrated management of mineral metabolism, inflammation, and bone health is essential for cardiovascular risk reduction in CKD.